A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.
European Projects
To find more information, please, get in touch with the International Management team at oficina.idi(ELIMINAR)@irycis.org
EURECA
FP7
European prospective cohort study on Enterobacteriaceae showing resistance to carbapenems
ANTICIPATE
FP7
Assessment of the incidence of Clostridium difficile infections in hospitalized patients on antibiotic treatment
ARTHR-IS
FP7
Retrospective study to identify the incidence, risk factors and outcomes of prosthetic joint infection due to Staphylococcus aureus after primary knee or hip joint replacement
REVISIT
FP7
Phase III randomized, open-label, comparative clinical trial to determine the efficacy and safety of aztreonam-avibactam (ATM-AVI)
MPI-AGE
FP7
Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons.
R-GNOSIS
FP7
Resistance in Gram-Negative Organism: Studying intevention strategies.
PAR
FP7
Predicting antibiotic resistance
MON4STRAT
FP7
Therapeutic Beta-Lactams Monitoring for Stratified and dose adjusted treatment of hospital-acquired pneumonia: improved efficacy, decreased treatment length, and reduction of emergence of resistance
SENATOR
FP7
Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and nondrug Therapy in Older peRsons
EVOTAR
FP7
Evolution and transfer fo antibiotic resistance.